iShares US Pharmaceuticals ETF
IHE
IHE
87 hedge funds and large institutions have $259M invested in iShares US Pharmaceuticals ETF in 2014 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.73% less ownership
Funds ownership: 111.31% → 109.58% (-1.7%)
Holders
87
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$6.49M | |
| 2 | +$2.96M | |
| 3 | +$2.17M | |
| 4 |
Goldman Sachs
New York
|
+$2.07M |
| 5 |
AP
Advisors Preferred
Rockville,
Maryland
|
+$1.76M |
Top Sellers
| 1 | -$7.92M | |
| 2 | -$7.22M | |
| 3 | -$3.94M | |
| 4 |
Morgan Stanley
New York
|
-$1.95M |
| 5 |
Jane Street
New York
|
-$1.05M |